Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: only abstract available

Data source

Referenceopen allclose all

Reference Type:
secondary source
Title:
4-Aminoazobenzene
Author:
Beratergremium für Altstoffe (BUA)
Year:
1998
Bibliographic source:
BUA-Stoffbericht 217. BUA der Gesellschaft dt. Chemiker, S. Hirzel Wissenschaftliche Verlagsgesellschaft, Stuttgart
Reference Type:
study report
Title:
Unnamed
Year:
1993
Reference Type:
secondary source
Title:
IUCLID
Author:
ECB
Year:
2007
Bibliographic source:
ECB IUCLID Dataset
Report date:
2007

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
4-aminoazobenzene
EC Number:
200-453-6
EC Name:
4-aminoazobenzene
Cas Number:
60-09-3
Molecular formula:
C12H11N3
IUPAC Name:
4-[(E)-2-phenyldiazen-1-yl]aniline
Details on test material:
- Name of test material (as cited in study report): 4-Aminoazobenzene
- Analytical purity: 98.7%

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
no data

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
head only
Vehicle:
other: acetone/polyethyleneglycol (1:1)
Details on inhalation exposure:
TEST ATMOSPHERE (if not tabulated)
- MMAD (Mass median aerodynamic diameter): 62 - 93% of the aerosol particles had a MMAD of ≤ 3µm


Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
0, 0.023, 0.341, 2.80 mg/l analytical concentration
No. of animals per sex per dose:
5 female and 5 male animals per dose
Control animals:
yes
Details on study design:
- Duration of observation period following administration: no data
- Frequency of observations and weighing: no data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 2.8 mg/L air
Exp. duration:
4 h
Mortality:
no mortality occured
Clinical signs:
other: at mid and high dose bradypnoe, cyanosis; reduced body temperature at mid and high dose; dose dependent increase in methemoglobin concentration (marginal at low dose); no symptoma of intoxication reported on the 4th day after exposure
Body weight:
reduced body weight gain at high dose
Gross pathology:
no treatment related effects observed at macroscopical pathology

Applicant's summary and conclusion